Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

cyclopia sequence 14 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Multiple Myeloma 3 Breast Neoplasms 3 Pain 2 Neoplasms, Plasma Cell 2 Head and Neck Neoplasms 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Thromboembolism 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Spinal Cord Neoplasms 1 Sleepiness 1 Sezary Syndrome 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Cognitive Complications 1 Peripheral Nervous System Diseases 1 Peptic Ulcer 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Parasomnias 1 Pancreatic Neoplasms 1 Osteosarcoma 1

Interventions

Gels 2 Fulvestrant 2 Doxycycline 2 Dapsone 2 ruxolitinib 1 dexpanthenol 1 ceterizine hydrochloride 1 capivasertib 1 benralizumab 1 Triamcinolone Acetonide 1 Tetracycline 1 Sirolimus 1 Provitamins 1 Prednisone 1 Panitumumab 1 Minocycline 1 Loperamide 1 Irinotecan 1 IFL protocol 1 Hydrocortisone 1 Erlotinib Hydrochloride 1 Clindamycin 1 Cetuximab 1 Anti-Bacterial Agents 1 Alpelisib 1 Acitretin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Exanthema × Minocycline × Clear all

NCT00473083 2017-04-04

LUTRAERL

British Columbia Cancer Agency

Phase 2 Completed

150 enrolled 13 charts

Exanthema, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡